Pill with imprint TEVA 5907 TEVA 5907 is Clear, Capsule-shape and has been identified as Mesalamine Delayed-Release 400 mg. It is supplied by Teva Pharmaceuticals USA, Inc.

Mesalamine is used in the treatment of Crohn's Disease, Maintenance; Ulcerative Colitis, Maintenance; Inflammatory Bowel Disease; Ulcerative Colitis, Active; Ulcerative Proctitis and belongs to the drug class 5-aminosalicylates. excluding Asacol and Asacol HD: There is no proven risk in humans during pregnancy. Asacol and Asacol HD: Risk cannot be ruled out during pregnancy. Mesalamine 400 mg is not a controlled substance under the Controlled Substances Act (CSA).